Skip to main content
PREVIEW · SAMPLE DATA
This is the CGON dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for CGON.

CGON

CG Oncology, Inc.
Healthcare · Biotechnology
$166.15 sample
-1.48 (-0.88%) 1D
☆ Watch
Market cap
$408.2B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-19
Alerts
8
Price$166.15 +20.01% 3M daily closessample
167.63135.19
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 27INSInsider sell: Director
  • Oct 22INSInsider buy: Chief Financial Officer
  • Oct 19SEC8-K filed: material event
  • Oct 13INSInsider sell: EVP, Operations
  • Oct 07INSInsider sell: Director
  • Sep 29INSInsider sell: Chief Executive Officer
  • Sep 18SEC8-K filed: material event
  • Sep 09INSInsider sell: Director
Sign up to see the real CGON record →

Company facts

SEC EDGAR registration
Name
CG Oncology, Inc.
Sector
Healthcare
Industry
Biotechnology
Smart-money score
-24sample, -100 to +100
Reporting currency
USD

Who is positioning in CGON

sample
Insiders
34 insider transactions over 90 days, net selling, $530.0M
Congress
No member trades over 90 days
Institutions · 13F
25 funds hold $3.4B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$22.5B +16.8% y/y
Q4 2024Q3 2026
Inventory$13.2B +11.9% y/y
Q4 2024Q3 2026
Accounts receivable$10.4B +18.4% y/y
Q4 2024Q3 2026
Total debt$26.4B +12.0% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$81.2B -0.8% 3M
Sample peer B
$266.4B +3.2% 3M
Sample peer C
$321.9B +0.2% 3M
Sample peer D
$383.8B -9.8% 3M
Sample peer E
$82.8B +1.5% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not CGON's real figure. Nothing here is investment advice.